These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31508234)

  • 1. Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792.
    Sasaki M; Miyahisa I; Itono S; Yashiro H; Hiyoshi H; Tsuchimori K; Hamagami KI; Moritoh Y; Watanabe M; Tohyama K; Sasaki M; Sakamoto JI; Kawamoto T
    Pharmacol Res Perspect; 2019 Oct; 7(5):e00517. PubMed ID: 31508234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice.
    Yashiro H; Hamagami K; Hiyoshi H; Sugama J; Tsuchimori K; Yamaguchi F; Moritoh Y; Sasaki M; Maekawa T; Yamada Y; Watanabe M
    Diabetes Obes Metab; 2019 Oct; 21(10):2228-2239. PubMed ID: 31144422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteropeptidase inhibitor SCO-792 effectively prevents kidney function decline and fibrosis in a rat model of chronic kidney disease.
    Katayama Y; Sugama J; Suzuki T; Ishimura Y; Kobayashi A; Moritoh Y; Watanabe M
    Nephrol Dial Transplant; 2021 Mar; 36(4):631-640. PubMed ID: 33351150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.
    Sugama J; Katayama Y; Moritoh Y; Watanabe M
    Diabetes Obes Metab; 2021 Jan; 23(1):86-96. PubMed ID: 32893449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits.
    Sun W; Zhang X; Cummings MD; Albarazanji K; Wu J; Wang M; Alexander R; Zhu B; Zhang Y; Leonard J; Lanter J; Lenhard J
    J Pharmacol Exp Ther; 2020 Dec; 375(3):510-521. PubMed ID: 33033171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SCO-792, A Novel Enteropeptidase Inhibitor, In the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Rashid MY; Noor A; Patel V; Henin S; Cuello-Ramírez A; Al Kaabi AS; Gnawali A; Mostafa JA
    Cureus; 2021 Mar; 13(3):e13724. PubMed ID: 33833935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity.
    Ikeda Z; Kakegawa K; Kikuchi F; Itono S; Oki H; Yashiro H; Hiyoshi H; Tsuchimori K; Hamagami K; Watanabe M; Sasaki M; Ishihara Y; Tohyama K; Kitazaki T; Maekawa T; Sasaki M
    J Med Chem; 2022 Jun; 65(12):8456-8477. PubMed ID: 35686954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain.
    Lu D; Yuan X; Zheng X; Sadler JE
    J Biol Chem; 1997 Dec; 272(50):31293-300. PubMed ID: 9395456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.
    Prohaska TA; Wahlmüller FC; Furtmüller M; Geiger M
    PLoS One; 2012; 7(6):e39262. PubMed ID: 22723979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors.
    Kikuchi F; Ikeda Z; Kakegawa K; Nishikawa Y; Sasaki S; Fukuda K; Takami K; Banno Y; Nishikawa H; Taya N; Nakahata T; Itono S; Yashiro H; Tsuchimori K; Hiyoshi H; Sasaki M; Tohyama K; Matsumiya K; Ishihara Y; Kawamoto T; Kamaura M; Watanabe M; Kitazaki T; Maekawa T; Sasaki M
    Bioorg Med Chem; 2023 Oct; 93():117462. PubMed ID: 37683572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and characterization of human enteropeptidase catalytic subunit in Escherichia coli.
    Gasparian ME; Ostapchenko VG; Schulga AA; Dolgikh DA; Kirpichnikov MP
    Protein Expr Purif; 2003 Sep; 31(1):133-9. PubMed ID: 12963350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of enteropeptidase light chain complexed with an analog of the trypsinogen activation peptide.
    Lu D; Fütterer K; Korolev S; Zheng X; Tan K; Waksman G; Sadler JE
    J Mol Biol; 1999 Sep; 292(2):361-73. PubMed ID: 10493881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome.
    Zhang X; Zhu B; Sun W; Wang M; Albarazanji K; Ghosh B; Cummings M; Lenhard J; Leonard J; Macielag M; Lanter J
    Bioorg Med Chem Lett; 2021 May; 40():127939. PubMed ID: 33713780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of a new synthetic substrate to the determination of enteropeptidase in rat small intestine and human intestinal biopsies.
    Antonowicz I; Hesford FJ; Green JR; Grogg P; Hadorn B
    Clin Chim Acta; 1980 Feb; 101(1):69-76. PubMed ID: 6987011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of enteropeptidase in the digestion of protein and its development in human fetal small intestine.
    Antonowicz I
    Ciba Found Symp; 1979 Jan 16-18; (70):169-87. PubMed ID: 396133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An inhibitor of enteropeptidases and trypsin from the bovine duodenum].
    Mikhaĭlova AG; Evtiukova NG; Chupova LA; Rumsh LD
    Vopr Med Khim; 1998; 44(4):338-46. PubMed ID: 9845920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary DNA cloning and sequencing of rat enteropeptidase and tissue distribution of its mRNA.
    Yahagi N; Ichinose M; Matsushima M; Matsubara Y; Miki K; Kurokawa K; Fukamachi H; Tashiro K; Shiokawa K; Kageyama T; Takahashi T; Inoue H; Takahashi K
    Biochem Biophys Res Commun; 1996 Feb; 219(3):806-12. PubMed ID: 8645262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Human Pancreatic Proteolytic Enzymes: The Role of Enteropeptidase and Trypsin.
    Freiburghaus AU; Roduner J; Hadorn HB
    JPGN Rep; 2021 Nov; 2(4):e138. PubMed ID: 37206452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lanthanide ions on enteropeptidase-catalyzed activation of trypsinogen.
    Rinderknecht H; Friedman RM
    Biochim Biophys Acta; 1976 Dec; 452(2):497-502. PubMed ID: 1009124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bile acids and pH on the release of enteropeptidase in man.
    Rinderknecht H; Nagaraja MR; Adham NF
    Am J Dig Dis; 1978 Apr; 23(4):332-6. PubMed ID: 27091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.